Ann: Symbol Undertakes Oversubscribed Capital Raising of A$3.0m, page-66

First 66 Last

Share
Profile

Follow
bhavdip143

503 Posts.

43

28/05/18

16:40

Post #: 33339729
Share

Originally posted by bhavdip143 ↑

None of these "concerns " would matter if and when Macy will go into production . At 17.5 Mil Mcap , It will be the cheapest Zinc Producer available on ASX . Massive re-rate is coming in SL1 IMO .Some short term triggers are as follows :

1) Complete Regulatory Approvals to Commence Mining in next few weeks

2) Award Mining Contract and Mobilize mining fleet in June

3) Macy PreMining Activities in June

4) Macy Mining and Processing and Aisha Drilling Results in July/August

5) Macy’s First Product , Macy’s 1st Shipment and Aisha JORC in August / September

6) Aisha Scoping Study in September / October

We should assume 2 to 4 weeks delays here and there for the reason that its in Nigeria but if management will be able to respect the timeline , We are looking at 3 to 5 X returns in next 6 months .

In current depressed market condition , I am personally leaning towards solid risk/reward plays and SL1 fits my criteria of a solid RR play .

DYOR
GLTAH

B

Expand

I am very much impressed with the speed of development Happening at Macy . In Presentation last month we were told Mining coctract will be awarded in June but its already in place now . Let's hope they will meet the timeline with the production and 3c SP will be a history once it will re-rate.

DYOR .

SL1 Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

EDE

Empire Energy locks in $65M funding deal with Macquarie to develop NT's Beetaloo Basin

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 10 more messages in this thread...

First 66 Last

Add SL1 (ASX) to my watchlist

Ann: Symbol Undertakes Oversubscribed Capital Raising of A$3.0m, page-66

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Empire Energy locks in $65M funding deal with Macquarie to develop NT's Beetaloo Basin

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game